News Summary:
Iqvia's Senior Director Product & Strategy, Mike King, brings over two decades of experience in healthcare and life sciences, having joined the company in 2022 after holding senior leadership positions at Dentsply Sirona and GE Healthcare, where he oversaw regulatory affairs across international markets. Previously, on August 19, 2026, Dr. Padmalakshmi Jnaneshwar, Director Safety Operations in Lifecycle Safety at Iqvia, shared insights on materiovigilance, explaining her role in leading safety operations, regulatory reporting, and project management teams that support medical device pharmacovigilance and drug safety for clinical trials and post-marketing products. Earlier, on August 17, 2026, Everest Group ranked Iqvia as the No. 1 Pharmaceutical Technology Provider. This follows an August 6, 2026, focus by Iqvia on solving the challenge for pharmaceutical commercial teams to reliably integrate its prescriber and claims data with Veeva’s CRM engagement data, emphasizing the importance of a data engineering layer for a solution.
Subscribe for full access to Iqvia's products in full detail 
